U.S. Physical Therapy, Inc.
NYSE:USPHMedical - Care Facilities
+$0.12 today
- Market cap
- $1.42B
- Beta
- 1.16
- P/E (TTM)
- 810.7
- EPS (TTM)
- $0.08
- Dividend yield
- 2.89%
Volume 0.33M
Average 0.20M
USPH Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
U.S. Physical Therapy, Inc.NYSE: USPH
Financing Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Financing cash flow growth accelerates
Q1 FY2026 financing cash flow of $28.86M rose 216.3% year over year, ahead of the +4.5% change in trailing-twelve-month financing cash flow.
Context
- Financing cash flow amounted to 5.7% of revenue in FY2025, up 0.1 pp from a year earlier.
- Financing cash flow increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +216.3% holds above the trailing-twelve-month pace of +4.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (44.14M) USD
- Year-over-year change
- -19.4%
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (44.14M) | -19.4% |
| FY2024 | 2024-12-31 | (36.95M) | -143.9% |
| FY2023 | 2023-12-31 | 84.27M | +227.1% |
| FY2022 | 2022-12-31 | 25.76M | -40.6% |
| FY2021 | 2021-12-31 | 43.38M | — |
Financing Cash Flow vs competitors
How USPH compares with its peers on the latest reported figures
- USPH's LTM Mar 2026 financing cash flow of $24.4M is the 10th largest of the 11 companies compared; the peer median is $50.12M.
- Its year-over-year change of +4.5% is the 6th highest of 11, against a peer median of +10.9%.
- Financing cash flow amounts to 3.3% of revenue for USPH, versus a peer median of 9.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $648.66M | +56.8% | +53.6% | — | |
| LTM Mar 2026 | $597.53M | +3986.4% | — | 16.9% | |
| LTM Jan 2026 | $361.98M | +183.3% | — | 432.4% | |
| LTM Apr 2026 | $193.59M | -34.7% | +66.0% | 6.8% | |
| LTM Mar 2026 | $166.09M | -58.1% | +67.2% | 3.0% | |
| LTM Mar 2026 | $145.87M | -48.2% | +24.9% | 18.5% | |
| LTM Mar 2026 | $129.98M | -20.0% | — | 9.5% | |
| LTM Mar 2026 | $116.62M | +41.7% | +142.6% | 11.4% | |
| LTM Mar 2026 | $81.23M | +51.0% | +17.6% | 4.4% | |
| LTM Mar 2026 | $24.4M | +4.5% | — | 3.3% | |
| LTM Aug 2026 | $19.01M | -81.4% | -5.6% | 2.2% | |
| Peer median (excluding USPH) | $50.12M | +10.9% | +53.6% | 9.5% | |
Competitors are the stored peer set for USPH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 57.92M | 43.41M | 37.22M | 45.6M | 58.01M |
| Depreciation & Amortization | 11.59M | 14.74M | 15.7M | 18.68M | 22.39M |
| Deferred Income Tax | 5.69M | 4.31M | 4.49M | 5.37M | 11.41M |
| Stock-Based Compensation | 7.87M | 7.26M | 7.24M | 7.82M | 8.27M |
| Change in Working Capital | (11.78M) | (21.43M) | (4.93M) | (12.4M) | (27.19M) |
| Accounts Receivables | (10.96M) | (10.28M) | (6M) | (11.89M) | (9.06M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | (7.76M) | 15K | 0 | (7.8M) |
| Other Working Capital | (824K) | (3.4M) | 1.06M | (510K) | (10.33M) |
| Other Non-Cash Items | 5.12M | 10.24M | 22.27M | 9.88M | 2.18M |
| Operating Cash Flow | 76.41M | 58.54M | 81.98M | 74.94M | 75.06M |
| Capital Expenditures | (8.2M) | (8.25M) | (9.29M) | (9.19M) | (14.07M) |
| Acquisitions (Net) | (116.09M) | (74.28M) | (36.87M) | (142.04M) | (24.95M) |
| Purchases of Investments | 0 | (373K) | 0 | 0 | 0 |
| Sales of Investments | 0 | 373K | 0 | 0 | 0 |
| Other Investing Activities | 152K | 1.26M | 1.15M | 1.77M | 2.31M |
| Investing Cash Flow | (124.14M) | (81.27M) | (45.02M) | (149.45M) | (36.71M) |
| Debt Repayment | 93.1M | 64.2M | (39.15M) | 4.3M | 8.06M |
| Common Stock Issued | 0 | 0 | 163.65M | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | (5.57M) |
| Dividends Paid | (18.77M) | (21.32M) | (24.13M) | (26.54M) | (27.36M) |
| Other Financing Activities | (30.96M) | (17.12M) | (16.1M) | (14.71M) | (19.27M) |
| Financing Cash Flow | 43.38M | 25.76M | 84.27M | (36.95M) | (44.14M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (4.35M) | 3.03M | 121.23M | (111.46M) | (5.79M) |
| Free Cash Flow | 68.21M | 50.29M | 72.68M | 65.75M | 60.99M |
U.S. Physical Therapy, Inc.
NYSE:USPH
Intrinsic Alpha fair value
Locked
Current Price
$95.43
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.